Liquidia Corporation (LQDA:NASDAQ) closed at $57.41 on November 13, 2026, down 1.22% on the day. The stock trades 38.7% below its 52-week high of $93.61 and 157.3% above its 52-week low of $22.31. Over the past year, it gained 104.7%. Liquidia Corporation is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 13, 2025, LQDA closed higher on 141 days (56%). Its best day was October 14, 2026 (+26.59%) and its worst was September 30, 2026 (-57.19%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.
Find more stocks like LQDA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.